Trial site
Centro Medico Teknon - Grupo Quironsalud
- 15running trials
- 14closed trials
The trials here
What the 29 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis10 trials
- Crohn's disease5 trials
- Macular degeneration5 trials
- Obesity5 trials
- Chronic rhinosinusitis with nasal polyps3 trials
- Obstructive sleep apnoea2 trials
- Type 2 diabetes2 trials
- Chronic kidney disease1 trial
- Eosinophilic oesophagitis1 trial
- Phase
- Phase 214 trials
- Phase 313 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Completed14 trials
- Recruiting9 trials
- Active, not recruiting4 trials
- Not yet recruiting2 trials
- Lead sponsor
- Hoffmann-La Roche6 trials
- Sanofi4 trials
- Abivax S.A.3 trials
- Amgen Inc.2 trials
- Eli Lilly & Co.2 trials
- and 11 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Recruiting
Recruiting
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Recruiting
Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity4 recruiting
- Macular degeneration3 recruiting
- Crohn's disease2 recruiting
- Obstructive sleep apnoea2 recruiting
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Type 2 diabetes1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease
Completed
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Active, not recruiting
Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis
Active, not recruiting
Effects of ABX464 during long-term treatment in patients with moderate to severe ulcerative colitis
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026